Evidence map›Paper›PMID 26854666›Full record

ArticleNature chemical biology2016

A transcription activator-like effector (TALE) induction system mediated by proteolysis.

Matthew F Copeland, Mark C Politz, Charles B Johnson, Andrew L Markley, Brian F Pfleger

Abstract read
In one paragraph

Article in Nature chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Selective recognition ofPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2018
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Genome-Editing Technologies: Principles and Applications.Cold Spring Harbor perspectives in biology · 2016
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Matthew F CopelandUniversity of Wisconsin-Madison, Department of Chemical and Biological Engineering, Madison, Wisconsin, USA.
Mark C PolitzUniversity of Wisconsin-Madison, Department of Chemical and Biological Engineering, Madison, Wisconsin, USA.
Charles B JohnsonUniversity of Wisconsin-Madison, Department of Chemical and Biological Engineering, Madison, Wisconsin, USA.
Andrew L MarkleyUniversity of Wisconsin-Madison, Department of Chemical and Biological Engineering, Madison, Wisconsin, USA.
Brian F PflegerUniversity of Wisconsin-Madison, Department of Chemical and Biological Engineering, Madison, Wisconsin, USA.ORCID http://orcid.org/0000-0002-9232-9959
University of Wisconsin–Madison · US

Funding

BIOTECHNOLOGY TRAINING PROGRAMT32GM008349 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI FOX, BRIAN G · 1989 to 2019
$22.5M
Institutional Training in the Genomic SciencesT32HG002760 · NHGRI · UNIVERSITY OF WISCONSIN-MADISON · PI Qiongshi Lu · 2003 to 2026
$17.7M
NHGRI NIH HHS T32 HG002760NIGMS NIH HHS T32 GM008349
6 · The paper itself

Abstract

Simple and predictable trans-acting regulatory tools are needed in the fields of synthetic biology and metabolic engineering to build complex genetic circuits and optimize the levels of native and heterologous gene products. Transcription activator-like effectors (TALEs) are bacterial virulence factors that have recently gained traction in biotechnology applications owing to their customizable DNA-binding specificity. In this work we expanded the versatility of these transcription factors to create an inducible TALE system by inserting tobacco-etch virus (TEV) protease recognition sites into the TALE backbone. The resulting engineered TALEs maintain transcriptional repression of their target genes in Escherichia coli, but are degraded after induction of the TEV protease, thereby promoting expression of the previously repressed target gene of interest. This TALE-TEV technology enables both repression and induction of plasmid or chromosomal target genes in a manner analogous to traditional repressor proteins but with the added flexibility of being operator-agnostic.

Indexed as

ProteolysisEndopeptidasesEscherichia coliGene Expression RegulationGenetic EngineeringPlasmidsPromoter Regions, GeneticRepressor ProteinsSynthetic BiologyTranscription FactorsVirulence FactorsEndopeptidasesRepressor ProteinsTEV proteaseTranscription FactorsVirulence Factors

Identifiers

PMID26854666
PMCPMC4809019
OpenAlexW2256853108

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.